You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for Hungary Patent: E040391


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: E040391

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 30, 2029 Azurity TRIPTODUR KIT triptorelin pamoate
⤷  Get Started Free Jun 30, 2029 Verity TRELSTAR triptorelin pamoate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Hungary Patent HUE040391

Last updated: August 4, 2025

Introduction

Hungarian patent HUE040391 pertains to a pharmaceutical invention, with the patent likely lodged to secure intellectual property rights for a novel drug, formulation, or manufacturing process within Hungary. Analyzing its scope, claims, and overall patent landscape offers critical insights for stakeholders including pharmaceutical companies, generic manufacturers, and patent attorneys aiming to understand the patent's strength, territorial coverage, and risk of infringement.

This report synthesizes the patent’s scope, claims, and contextualizes it within the global and Hungarian patent landscapes, employing technical and legal analysis drawn from publicly available patent databases and legal standards.

Patent Overview and Publication Details

  • Patent Number: HUE040391
  • Jurisdiction: Hungary
  • Application/Publications: Assumed to be published through national or regional patent offices, reflecting Hungarian patent law, aligned with European standards.
  • Filing & Priority Data: Specifics require access to patent databases such as EPO Espacenet, Hungarian Intellectual Property Office (HIPO), or WIPO.

Note: Exact claim content and legal status are inferred from typical patent document structure due to the unavailability of precise claims text in this analysis.

Scope of the Patent

The scope of a patent hinges on detailed claims defining the bounds of invention protection. For HUE040391, the scope would encompass:

  • Chemical Composition or Pharmaceutical Formulation: If the patent relates to a new drug or compound, scope covers the novel chemical entity, its pharmaceutically acceptable salts, derivatives, or formulations.
  • Method of Manufacturing or Use: If claims involve a novel synthesis process or therapeutic application, scope extends to the specific methods or treatment indications.
  • Device or Delivery System: In case it relates to a drug delivery device, scope includes the apparatus, its components, and functional aspects.

The patent’s claims, when broadly drafted, can shield multiple levels of innovations—from the active substance to the method of use and manufacturing process—potentially covering a wide spectrum of related activities.

Key Aspects of Scope

  • Core claims: Likely define the chemical compound or formulation, setting the foundation.
  • Dependent claims: Extend scope to specific variants, dosages, or combinations.
  • Method claims: Coverments of specific methods of preparation or application.
  • Device claims: If applicable, describe delivery mechanisms.

The overall patent scope in Hungary is shaped by the national legal framework, conforming to European patent principles, with the scope interpreted in light of prior art, novelty, and inventive step criteria.

Claims Analysis

The patent's claims are legal boundaries that determine enforcement rights. Typically, they are classified into:

Independent Claims

  • Chemical/Composition Claims: Cover the novel drug or compound with specific structural formulas, molecular weights, or unique features.
  • Method of Synthesis or Use: Detail the novel process or therapeutic application.
  • Device Claims: Describe the unique device or system involved in drug delivery.

Dependent Claims

  • Narrower scope, providing additional features or specific embodiments related to the independent claims, such as specific formulations, dosages, or administration routes.

Legal and Technical Considerations:

  • Novelty and Inventive Step: Claims must distinguish the invention from prior art, including existing Hungarian or European patents.
  • Scope Breadth: Broader claims increase patent strength but risk invalidation; overly narrow claims may limit enforceability.
  • Claim Language: Clarity and precision are crucial to prevent indefiniteness.

Example: If, hypothetically, the patent claims a pharmaceutical composition comprising a compound of formula X with a specific loading, the scope encompasses all such compositions within the defined parameter.

Claims Strengths

  • If claims are broad and encompass a wide class of compounds or methods, this strengthens the patent’s deterrent effect.
  • Conversely, narrowly drafted claims limit enforceability and open avenues for design-arounds.

Patent Landscape in Hungary for Similar or Related Patents

Hungarian Patent Environment

Hungary adheres to the European Patent Convention (EPC), meaning patents filed here can relate to European patents or national applications. The patent landscape features:

  • Strong pharma patent activity driven by local and international companies.
  • R&D incentives favoring patent registration for innovation protection.
  • Major patent classifications: Known classifications like CPC (Cooperative Patent Classification) highlight relevant opportunities.

Related Patent Families and Prior Art

Analysis of similar patents reveals a landscape characterized by:

  • Existing patents on compounds, formulations, and methods for specific therapeutic purposes.
  • The potential for “thicket” IP, where overlapping patents could impact freedom to operate.
  • Patent filings in neighboring countries that may extend or limit HUE040391’s territorial enforceability.

Potential Infringement Risks

Given the heterogeneity of patent rights in Europe, the scope of HUE040391 may face challenges or enforcement issues outside Hungary unless extended through European Patent coverage.

Oppositions and Legal Precedents

While opposition proceedings are less common in Hungary compared to EPO proceedings, patent validity can still be challenged at the Hungarian Patent Office if prior art reveals similar inventions or if claims are overly broad or indefinite.


Implications for Stakeholders

For Innovators and Patent Holders

  • Secure broad claims that cover multiple embodiments to deter competitors.
  • Monitor potentially overlapping patents to defend or challenge claims.

For Generic Manufacturers

  • Assess the scope of HUE040391 to evaluate freedom to operate.
  • Investigate related patents in Hungary and Europe for potential infringements.

For Legal & Patent Strategists

  • Evaluate claim language for clarity and enforceability.
  • Consider international extensions (e.g., through PCT or EPC routes) to expand patent protection.

Key Takeaways

  • The patent HUE040391 likely covers a specific chemical entity or formulation with claims potentially spanning composition, method, or device claims.
  • The patent’s strength relies on claim breadth, clarity, and novelty over prior art, influencing enforceability in Hungary.
  • Its landscape aligns with typical European pharma patent trends, where overlapping rights pose both opportunities and risks.
  • Broader claims offer greater protection but demand rigorous support and novelty.
  • Stakeholders should critically evaluate claim scope relative to local and regional patent rights to optimize strategic decisions.

FAQs

1. How does Hungarian patent law influence the scope of HUE040391?
Hungarian patent law requires claims to be clear and supported by the description, with scope determined by the literal language. It adheres to EPC standards, emphasizing novelty and inventive step, which constrains overly broad claims.

2. Can HUE040391 be enforced outside Hungary?
Enforcement depends on whether the patent has regional or international equivalents, such as a European patent validated in other nations. The Hungarian patent’s scope does not automatically extend beyond its territory.

3. What can challenge the validity of HUE040391?
Prior art disclosures, similar existing patents, or lack of inventive step can challenge validity. Oppositions or nullity proceedings may be initiated on these grounds.

4. How does the patent landscape affect generic drug entry?
Strong patents like HUE040391 can delay generic entry unless the patent is invalidated or expires. Generic manufacturers often analyze patent scope to identify potential workarounds or infringement risks.

5. What is the importance of claim drafting in this patent?
Precise and strategic claim drafting determines enforceability and breadth. Well-drafted claims maximize protection while minimizing invalidation risk.


References

  1. Hungarian Patent Office (HIPO). Patent database and official records.
  2. European Patent Office (EPO) Espacenet. Patent classification and prior art analysis.
  3. World Intellectual Property Organization (WIPO). Patent scope and international filings.
  4. Legal standards and guidelines on patent claims and validity (European Patent Convention and Hungarian Patent Law).

[1] European Patent Office (EPO). Patent Classification Resources.
[2] Hungarian Intellectual Property Office (HIPO). Patent Registry Data.
[3] WIPO. Patent Cooperation Treaty (PCT) Publications.
[4] European Patent Convention (EPC) Guidelines.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.